| Martin Family Eyecare | |
|
925 Mally St, Tuscaloosa, AL 35405-8785 | |
| (205) 344-5111 | |
| (205) 344-5004 |
| Full Name | Martin Family Eyecare |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 925 Mally St, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225207889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | S846TA372 (Alabama) | Primary |
| Provider Name | Marston C Martin |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285607879 PECOS PAC ID: 8426078676 Enrollment ID: I20051208000968 |
News Archive
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
The key to better treatments for brain injuries and disease may lie in the molecules charged with preventing the clumping of specific proteins associated with cognitive decline and other neurological problems, researchers from the Perelman School of Medicine at the University of Pennsylvania report in a new study published in Neurobiology of Disease.
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
The greatest risk factor for Alzheimer's disease (AD) is advancing age. By age 85, the likelihood of developing the dreaded neurological disorder is roughly 50 percent. But researchers at the University of California, San Diego School of Medicine say AD hits hardest among the "younger elderly" - people in their 60s and 70s - who show faster rates of brain tissue loss and cognitive decline than AD patients 80 years and older.
A new study from Northwestern Medicine- has found that surgical researchers rarely use female animals or female cells in their published studies - despite a huge body of evidence showing that sex differences can play a crucial role in medical research.
› Verified 2 days ago
| Provider Name | Haley Henson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1003301664 PECOS PAC ID: 5799018537 Enrollment ID: I20190610001406 |
News Archive
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
The key to better treatments for brain injuries and disease may lie in the molecules charged with preventing the clumping of specific proteins associated with cognitive decline and other neurological problems, researchers from the Perelman School of Medicine at the University of Pennsylvania report in a new study published in Neurobiology of Disease.
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
The greatest risk factor for Alzheimer's disease (AD) is advancing age. By age 85, the likelihood of developing the dreaded neurological disorder is roughly 50 percent. But researchers at the University of California, San Diego School of Medicine say AD hits hardest among the "younger elderly" - people in their 60s and 70s - who show faster rates of brain tissue loss and cognitive decline than AD patients 80 years and older.
A new study from Northwestern Medicine- has found that surgical researchers rarely use female animals or female cells in their published studies - despite a huge body of evidence showing that sex differences can play a crucial role in medical research.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Martin Family Eyecare 925 Mally St, Tuscaloosa, AL 35405-8785 Ph: (205) 344-5111 | Martin Family Eyecare 925 Mally St, Tuscaloosa, AL 35405-8785 Ph: (205) 344-5111 |
News Archive
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
The key to better treatments for brain injuries and disease may lie in the molecules charged with preventing the clumping of specific proteins associated with cognitive decline and other neurological problems, researchers from the Perelman School of Medicine at the University of Pennsylvania report in a new study published in Neurobiology of Disease.
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
The greatest risk factor for Alzheimer's disease (AD) is advancing age. By age 85, the likelihood of developing the dreaded neurological disorder is roughly 50 percent. But researchers at the University of California, San Diego School of Medicine say AD hits hardest among the "younger elderly" - people in their 60s and 70s - who show faster rates of brain tissue loss and cognitive decline than AD patients 80 years and older.
A new study from Northwestern Medicine- has found that surgical researchers rarely use female animals or female cells in their published studies - despite a huge body of evidence showing that sex differences can play a crucial role in medical research.
› Verified 2 days ago
Dr. Haley Henson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 925 Mally St, Tuscaloosa, AL 35405 Phone: 205-344-5111 | |
Dr. Wesley A Dubose, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1800 Mcfarland Blvd E, Suite 406, Tuscaloosa, AL 35404 Phone: 205-342-0745 Fax: 205-345-0475 | |
Global Eye Care, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 1501 Skyland Blvd E, Tuscaloosa, AL 35405 Phone: 205-750-8529 Fax: 205-750-8971 | |
Dr. Carrie Elizabeth Smith, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 535 Jack Warner Pkwy Ne Ste B1, Tuscaloosa, AL 35404 Phone: 205-556-2121 Fax: 205-554-0152 | |
Dr. Nathan A Whitaker, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3701 Loop Rd, Tuscaloosa Vamc, Tuscaloosa, AL 35404 Phone: 205-554-2822 | |
Dr. Colleen Stanley Dent, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1401 Skyland Blvd E, In Sams Club Optical, Tuscaloosa, AL 35405 Phone: 205-345-3893 Fax: 205-345-3896 | |
Dr. Blaze Sammon, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3501 Mcfarland Blvd E, Tuscaloosa, AL 35405 Phone: 205-556-7950 |